| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Drug Discovery | 2 / 161 | 99th | Q1 |
| Pharmacology | 5 / 328 | 98th | Q1 |
| Molecular Medicine | 5 / 179 | 97th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Medicinal Research Reviews
Medicinal Research Reviews is Scopus-indexed (Q1, CiteScore 29.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley & Sons Inc..
Checked against the index lists dated .
ISSN 0198-6325Verify ISSN ↗1098-1128Verify ISSN ↗
Publisher: John Wiley & Sons Inc.
Cost to publish: About US$4,980 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Medicinal Research Reviews indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1981–present, best quartile Q1, CiteScore 29.1.
What quartile is Medicinal Research Reviews in Scopus?
Medicinal Research Reviews is Q1 in Drug Discovery (rank 2 of 161), Q1 in Pharmacology (rank 5 of 328) and Q1 in Molecular Medicine (rank 5 of 179), by CiteScore 2025.
What is the impact factor of Medicinal Research Reviews?
Medicinal Research Reviews is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 29.1, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.265, quartile Q1, with an H-index of 167.
How much does it cost to publish in Medicinal Research Reviews?
The publisher lists an article processing charge of about US$4,980 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Medicinal Research Reviews and what is its ISSN?
Medicinal Research Reviews is published by John Wiley & Sons Inc. Its print ISSN is 0198-6325 and its online ISSN is 1098-1128.
Is Medicinal Research Reviews covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Medicinal Research Reviews in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Medicinal Research Reviews open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Medicinal Research Reviews? — open metrics via OpenAlex
Medicinal Research Reviews has an h-index of 194 and a 2-year mean of 9.73 citations per paper (OpenAlex). Its Scopus CiteScore is 29.1, quartile Q1. On 2-year citations it ranks #4 of 159 Scopus journals in Drug Discovery.
Medicinal Research Reviews published 71 papers in 2025; its busiest recent year was 2020 with 120. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Medicinal Research Reviews? — latest 100 articles, 2025–2026
In its latest 100 research articles (2025–2026), authors are most often from China (46.6%), Italy (9.1%) and United States (6.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Medicinal Research Reviews? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (0.9 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 0.9 per 1,000 papers
- Problematic Paper Screener flags 1 · 0.5 per 1,000 papers — mostly suspect text
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.